How much better are their responses to the Q&A than previously.
- Non dilutive funding is focus most likely via China and possibly Latin America
- Knock back previous low ball offers for MPS but they have come back for OA as well
- DMOAD still on table (look out for MRI qualitative analysis in new few weeks....DS laughter somewhat telling)
- DMOAD label won't delay market release (DURATION is massive in isolation)
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-79
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.035(13.7%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 29.0¢ | 25.0¢ | $162.3K | 595.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49897 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 24504 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |